Erweiterte Suche

Siegfried Russwurm ist eine deutsche Unternehmerpersönlichkeit, die bereits an der Spitze von 10 verschiedenen Unternehmen stand. Derzeit ist Dr. Russwurm Vorsitzender des Aufsichtsrates der Voith GmbH, Vorsitzender des Aufsichtsrates der ThyssenKrupp AG, Vorsitzender des Aufsichtsrates der thyssenkrupp Elevator Europe Africa GmbH (eine Tochtergesellschaft der ThyssenKrupp AG), Präsident des Bundesverbandes der Deutschen Industrie e.V. und Vorsitzender für Siemens (Pty) Ltd. Siegfried Russwurm ist außerdem Mitglied der Deutschen Akademie der Technikwissenschaften e.V. und im Vorstand von 11 weiteren Unternehmen. In seiner bisherigen Laufbahn war Dr. Russwurm Mitglied des Vorstands der Siemens AG Vorsitzender des Aufsichtsrats der Siemens AG sterreich, Chief Executive Officer bei Siemens Industry, Inc. Vorsitzender für die Siemens Schweiz AG und Head-Electro Medical Systems bei Siemens-Elema AB (alles Tochtergesellschaften der Siemens AG), Vorsitzender des Aufsichtsrates der OSRAM Licht AG, Vorsitzender des Aufsichtsrates der OSRAM GmbH, Direktor bei Nokia Siemens Networks Oy und Vorsitzender der Technischen Mechanik an der Friedrich-Alexander Universität Erlangen-Nürnberg. Er promovierte an der Friedrich-Alexander-Universität Erlangen-Nürnberg.

Siegfried Reich gründete eFFECTOR Therapeutics, Inc. Dr. Reich ist Chief Scientific Officer & Executive VP bei Turning Point Therapeutics, Inc. In der Vergangenheit war er Vice President bei Pfizer Inc. und Director & Head-Medicinal Chemistry bei Agouron Pharmaceuticals LLC (einer Tochtergesellschaft von Pfizer Inc.), Senior Vice President-Research bei eFFECTOR Therapeutics, Inc. und Vice President-Drug Discovery bei SGX Pharmaceuticals, Inc. Siegfried Reich erwarb einen Bachelor-Abschluss an der San Diego State University und einen Doktortitel an der University of California, Irvine.

Herr Siegfried Mayrhofer ist Chief Financial Officer bei eTel Austria GmbH & Co. KG, Group Chief Financial Officer bei der Telekom Austria AG und Co-Geschäftsführer bei der Mobilkom Beteiligungsgesellschaft mbH. Er ist Mitglied des Board of Directors bei A1 Slovenija dd, A1 Hrvatska doo, Miami County Zoning Commission, one.Vip doo, Mobiltel AD, Si.mobil dd, Unitary Enterprise Velcom, Vip Mobile d.o.o. und Vip operator DOOEL. Herr Mayrhofer war zuvor als Chief Financial Officer & Member-Supervisory Board bei der A1 Telekom Austria AG beschäftigt. Er schloss sein Studium an der Technischen Universität Graz ab.

Zurzeit ist Siegfried Willi Kiefer President & Chief Executive Officer bei Canadian Utilities Ltd. und President, Chief Executive Officer & Director bei CU, Inc. (eine Tochtergesellschaft von Canadian Utilities Ltd.). Er ist außerdem Mitglied des Vorstands von ATCO Power Ltd. und ATCO Electric Ltd. sowie President & Chief Strategy Officer bei ATCO Ltd. Zuvor hatte er die Position des Präsidenten bei Wipro Solutions Canada Ltd. und des Managers-Utility Services bei ATCO Energy Solutions Ltd. inne. Siegfried Willi Kiefer erwarb einen Bachelor-Abschluss an der University of Calgary.

Siegfried Kreutzfeld is currently the Chief Executive Officer at Zest WEG Group Africa (Pty) Ltd.
He also holds the position of Director at WEG SA. In addition, he serves as a Director at Companhia Brasileira de Metalurgia & Mineracao and as a Member-Executive Board at WEG Equipamentos Elétricos SA, WEG Amazônia SA, RF Reflorestadora Ltda., and WEG Linhares Equipamentos Elétricos Ltda.
Mr. Kreutzfeld completed his undergraduate degree at the Federal University of Santa Catarina in 1996.
He then went on to earn a graduate degree from the same university in 1998.
Prior to that, he obtained an undergraduate degree from Santa Catarina State University in 1974.
He also holds undergraduate degrees from Centro Universitário de Jaraguá do Sul, earned in 1993, 1990, and 1988.

Stefan Russwurm is Chief Executive Officer, Chief Medial Officer and Founder of SIRS-Lab GmbH.
He was Senior Physician and Head of the Experimental Anaesthesiology Department at the University of Jena.
Dr. Russwurm holds a PhD in Molecular Medicine and Atherosclerosis.

Heinz Russwurm currently holds positions in Aop Orphan Pharmaceuticals GmbH, where he currently serves as Chairman-Supervisory Board.

Siegfried Wanker is currently the Chairman-Supervisory Board at AKA Alföld Koncessziós Autópálya Zrt., Chairman-Supervisory Board at Strabag Property & Facility Services GmbH, and Member-Supervisory Board at Strabag AG.
He is also a Member-Supervisory Board at Strabag Sp zoo, STRABAG AG (Austria), STRABAG Property & Facility Services GmbH (Austria), and Böhm Stadtbaumeister & Gebäudetechnik GmbH.
Previously, he served as Chairman-Supervisory Board at Strabag a.s., Member-Management Board at Bauholding Strabag SE, Member-Supervisory Board at Ilbau Liegenschaftsverwaltung AG, and Member-Management Board at BAU Holding Beteiligungs AG.
Mr. Wanker obtained his undergraduate degree from Graz University of Technology.

Siegfried Müller worked for Hochtief AG from 1981 to 2013, where he served as a Member-Supervisory Board from 2011 to 2013.
He also worked for ALPINE Bau GmbH as a Member-Management Board.

Siegfried Rohsmanith is currently working as a Location Manager & Senior Client Portfolio Manager at HRK LUNIS AG since 2023.
Prior to this, he worked as a Branch & Portfolio Manager at Huber, Reuss & Kollegen Vermögensverwaltung GmbH.

Mr. Siegfried Sauer is on the Board of Directors at Bremer Straßenbahn AG.
Mr. Sauer was previously employed as a Member-Supervisory Board by TÜV NORD AG.

Siegfried Selberherr is currently a Professor at Technische Universität Wien since 2011.
He previously served as the Vice Chairman-Supervisory Board at ams-OSRAM AG.

Siegfried Hauch is currently the Chief Scientific Officer at Alere Diagnostics GmbH.

Siegfried Heimgartner is currently a Board Member at Ageras A.
He previously worked as an Executive Vice President at Worldline IGSA SA.

Siegfried Weishaupt has held positions in Weishaupt SAS and Weishaupt SA. His current job titles are Co-Chairman at Weishaupt SAS and Director at Weishaupt SA.

Siegfried S.
Rogy worked as the Head of Clinical Operations at Maxim Pharmaceuticals, Inc. from 2004 to 2005, and at Baxter BioScience Corp.
from 2002 to 2010.
He also worked as the Senior Director of Clinical Operations at C3 Jian LLC and as the Vice President of Clinical Operations at Capricor Therapeutics, Inc. Additionally, he served as the Head of Clinical Operations and Business Development at The Medicines Co. from 2010 to 2012.
Rogy received his undergraduate and doctorate degrees from the University of Graz.

Siegfried Stumpf is currently the Chairman-Supervisory Board at ÖBB-Technische Services GmbH.
He previously worked as a Director at ÖBB-Personenverkehr AG and as a Member-Management Board at ÖBB-Infrastruktur AG.

Siegfried Kok is a Senior Portfolio Manager at OBAM Investment Management B.V.
He previously worked as a Fund Manager at ABN AMRO Asset Management (Netherlands).
BV, a Fund Manager at Van Lanschot Kempen Investment Management NV, a Portfolio Manager & Analyst at Aster-X Capital Management BV, a Senior Portfolio Manager at BNP PARIBAS ASSET MANAGEMENT Netherlands NV, and an Investment Manager at Oyens & Van Eeghen Investment Management BV.

Milann H.
Siegfried is currently the Chairman at St. John Medical Center, Inc., the Director at The NORDAM Group LLC, and a Trustee at The Papal Foundation.
Previously, she served as the Chairman & President of The Gilcrease Museum National Board, Chairman of Cascia Hall Preparatory School, and as a Trustee at the University of Portland, the University of Tulsa, and Eisenhower Health.

Siegfried Hanke is the founder of HANKE Gesellschaft für Gießerei-Kooperation mbH, where he holds the title of Managing Director & Managing Partner since 1993.
He is currently a Member-Supervisory Board at Stadtwerke Weißenfels GmbH.

Siegfried Schlestein has a current job as a Member-Management Board at Landgenossenschaft Pröttlin eG.